EcoDrugPlus

Protein Farnesyltransferase Subunit Beta-Like

Ensembl ID : ENSSFOG00015017319
Gene Symbol: LOC108919508
3 Cross references
209 Possible Orthologues:

Protein Kinase C Alpha

Ensembl ID : ENSSFOG00015005520
Gene Symbol: PRKCA
3 Cross references
213 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSSFOG00015020920
Gene Symbol: PRKCD
3 Cross references
205 Possible Orthologues:

Protein Kinase C Delta Type-Like

Ensembl ID : ENSSFOG00015019846
Gene Symbol: LOC108936999
3 Cross references
205 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSSFOG00015001283
Gene Symbol: PRKCE
3 Cross references
342 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSSFOG00015013146
Gene Symbol: PRKCH
3 Cross references
149 Possible Orthologues:

Protein Kinase C Iota Type

Ensembl ID : ENSSFOG00015008673
Gene Symbol: LOC108935260
3 Cross references
85 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSSFOG00015009687
Gene Symbol: PRKCZ
3 Cross references
201 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSSFOG00015004223
Gene Symbol: PRKCQ
1 Cross references
202 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSSFOG00015023840
Gene Symbol: PRKCQ
1 Cross references
202 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSSFOG00015014764
Gene Symbol: PRKD1
1 Cross references
204 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSSFOG00015009297
Gene Symbol: PRKD3
3 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).